Drug
Cefdinir
Cefdinir: highest development phase Phase 1, developed by Sandoz. 3 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cefdinir 300 mg Capsule (Sandoz, Austria) NCT00882700 | Phase 1 | Healthy |
| Cefdinir 250 mg/5 ml Oral Suspension (Sandoz, Austria) NCT00882570 | Phase 1 | Healthy |
| Cefdinir 250 mg/5 ml Suspension (Sandoz, Austria) NCT00883883 | Phase 1 | Healthy |
Latest
No recent events.
Follow Cefdinir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.